About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID 		Rev3ltm2.1Rwd
targeted mutation 2.1, Richard D Wood
MGI:4441207
Summary 3 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cn1
 		Rev3ltm1Rwd/Rev3ltm2.1Rwd
Trp53tm1Brd/Trp53tm1Brd
Tg(MMTV-cre)1Mam/0 		involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * FVB/N MGI:4441274
cn2
 		Rev3ltm1Rwd/Rev3ltm2.1Rwd
Trp53tm1Brd/Trp53+
Tg(MMTV-cre)1Mam/0 		involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * FVB/N MGI:4441276
cn3
 		Rev3ltm1Rwd/Rev3ltm2.1Rwd
Tg(MMTV-cre)1Mam/0 		involves: 129P2/OlaHsd * C57BL/6 * FVB MGI:4441273


Genotype
MGI:4441274
cn1
Allelic
Composition		 Rev3ltm1Rwd/Rev3ltm2.1Rwd
Trp53tm1Brd/Trp53tm1Brd
Tg(MMTV-cre)1Mam/0
Genetic
Background		 involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rev3ltm1Rwd mutation (0 available); any Rev3l mutation (120 available)
Rev3ltm2.1Rwd mutation (2 available); any Rev3l mutation (120 available)
Tg(MMTV-cre)1Mam mutation (1 available)
Trp53tm1Brd mutation (5 available); any Trp53 mutation (240 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
mortality/aging
premature death ( J:158922 )
• mean survival is 91 days compared with 134 to 117 days for Trp53tm1Brd homozygous control mice

neoplasm
increased T cell derived lymphoma incidence ( J:158922 )
• in all mice develop thymic lymphomas compared with 70% to 77% of Trp53tm1Brd homozygous control mice
• tumors are frequently oligoclonal
• incidence of thymic lymphomas is increased while latency to development of tumors is decreased compared with Trp53tm1Brd homozygous control mice

endocrine/exocrine glands
increased T cell derived lymphoma incidence ( J:158922 )
• in all mice develop thymic lymphomas compared with 70% to 77% of Trp53tm1Brd homozygous control mice
• tumors are frequently oligoclonal
• incidence of thymic lymphomas is increased while latency to development of tumors is decreased compared with Trp53tm1Brd homozygous control mice

immune system
increased T cell derived lymphoma incidence ( J:158922 )
• in all mice develop thymic lymphomas compared with 70% to 77% of Trp53tm1Brd homozygous control mice
• tumors are frequently oligoclonal
• incidence of thymic lymphomas is increased while latency to development of tumors is decreased compared with Trp53tm1Brd homozygous control mice

hematopoietic system
increased T cell derived lymphoma incidence ( J:158922 )
• in all mice develop thymic lymphomas compared with 70% to 77% of Trp53tm1Brd homozygous control mice
• tumors are frequently oligoclonal
• incidence of thymic lymphomas is increased while latency to development of tumors is decreased compared with Trp53tm1Brd homozygous control mice




Genotype
MGI:4441276
cn2
Allelic
Composition		 Rev3ltm1Rwd/Rev3ltm2.1Rwd
Trp53tm1Brd/Trp53+
Tg(MMTV-cre)1Mam/0
Genetic
Background		 involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rev3ltm1Rwd mutation (0 available); any Rev3l mutation (120 available)
Rev3ltm2.1Rwd mutation (2 available); any Rev3l mutation (120 available)
Tg(MMTV-cre)1Mam mutation (1 available)
Trp53tm1Brd mutation (5 available); any Trp53 mutation (240 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
neoplasm
increased mammary gland tumor incidence ( J:158922 )
• 11 of 36 mice develop mammary tumors consisting of solid carcinoma, carcinosarcoma, adenosquamous carcinoma, and osteosarcoma
• incidence of mammary tumors is increased while latency to development of tumors is decreased compared with Trp53tm1Brd heterozygotes
increased carcinoma incidence ( J:158922 )
• in the mammary tissue of some mice
increased osteosarcoma incidence ( J:158922 )
• in the mammary tissue of one mouse

integument
increased mammary gland tumor incidence ( J:158922 )
• 11 of 36 mice develop mammary tumors consisting of solid carcinoma, carcinosarcoma, adenosquamous carcinoma, and osteosarcoma
• incidence of mammary tumors is increased while latency to development of tumors is decreased compared with Trp53tm1Brd heterozygotes

skeleton
increased osteosarcoma incidence ( J:158922 )
• in the mammary tissue of one mouse

endocrine/exocrine glands
increased mammary gland tumor incidence ( J:158922 )
• 11 of 36 mice develop mammary tumors consisting of solid carcinoma, carcinosarcoma, adenosquamous carcinoma, and osteosarcoma
• incidence of mammary tumors is increased while latency to development of tumors is decreased compared with Trp53tm1Brd heterozygotes




Genotype
MGI:4441273
cn3
Allelic
Composition		 Rev3ltm1Rwd/Rev3ltm2.1Rwd
Tg(MMTV-cre)1Mam/0
Genetic
Background		 involves: 129P2/OlaHsd * C57BL/6 * FVB
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rev3ltm1Rwd mutation (0 available); any Rev3l mutation (120 available)
Rev3ltm2.1Rwd mutation (2 available); any Rev3l mutation (120 available)
Tg(MMTV-cre)1Mam mutation (1 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
neoplasm
increased mammary gland tumor incidence ( J:158922 )
• 6 of 24 mice develop mammary tumors consisting of carcinosarcoma, solid carcinoma, and adenosquamous carcinoma
increased carcinoma incidence ( J:158922 )
• in the mammary tissue of some mice

integument
increased mammary gland tumor incidence ( J:158922 )
• 6 of 24 mice develop mammary tumors consisting of carcinosarcoma, solid carcinoma, and adenosquamous carcinoma

endocrine/exocrine glands
increased mammary gland tumor incidence ( J:158922 )
• 6 of 24 mice develop mammary tumors consisting of carcinosarcoma, solid carcinoma, and adenosquamous carcinoma




Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
11/19/2024
MGI 6.24 		The Jackson Laboratory